Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04544592 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Name: UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL — clinical trial record (NCT04544592)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1/2

SponsorUniversity of Colorado, Denver

Started2021-03-10

View on ClinicalTrials.gov ↗

This phase I/II trial will investigate a new CD19 directed CAR-T therapy manufactured locally with the goals to expedite infusion to wider patient inclusion that includes those who were previously excluded, such as pediatric patients with B-cell NHL and patients in primary relapse.

Amendment history 2 changes detected by DataLookout

2026-09-15

Primary completion pushed: 2026-06 → 2030-03-10

2026-09-15

Completion pushed: 2026-07 → 2031-03-10

Trial Details

NCT Number	NCT04544592
Lead Sponsor	University of Colorado, Denver Collaborators: Children's Hospital Colorado
Conditions	B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma
Enrollment	45 participants
Start Date	2021-03-10
Primary Completion	2030-03-10 (estimated)
Study Completion	2031-03-10 (estimated)
Updated on ClinicalTrials.gov	2026-09-14